Uptrend on the daily chart: above its 50- and 200-day averages · 50-day below the 200-day · SuperTrend up · inside the Ichimoku cloud · RSI 100 (overbought) · MACD below its signal · at its 52-week high
None of the 29 investors followed here reported a position in MRPI in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a MRPI trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
No insider transactions reported for MRPI.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0% | ||
| 2025 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0% |
| 2024 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0% |
| 2023 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0% |
| 2022 | 0.0 | 0.0 | 50.0 | 0.0 | -33.3 | 0.0 | 0.0 | -50.0 | 0.0 | 0.0 | 0.0 | 0.0 | −50.0% |
| 2021 | 129.2 | 27.3 | 41.1 | -7.3 | -23.0 | 12.8 | -18.9 | -23.3 | -94.9 | 100.0 | -80.0 | 0.0 | −95.8% |
| 2020 | 0.0 | -50.0 | 0.0 | 0.0 | 200.0 | 33.3 | -18.7 | 53.8 | -60.0 | 25.0 | 20.0 | 700.0 | +1100.0% |
| 2019 | 0.0 | 12.5 | -11.1 | 0.0 | 25.0 | -40.0 | 100.0 | -16.7 | 0.0 | -40.0 | -33.3 | 100.0 | 0.0% |
| 2018 | -37.5 | 0.0 | -20.0 | 0.0 | 0.0 | 5.0 | 31.0 | -27.3 | 50.0 | -16.7 | -20.0 | 0.0 | −50.0% |
| 2017 | -6.7 | 158.6 | -17.1 | -50.0 | 0.0 | 0.0 | 33.3 | -50.0 | -10.0 | 111.1 | -26.3 | -42.9 | −46.7% |
| 2016 | 50.0 | 0.0 | -33.3 | 450.0 | -54.5 | 20.0 | -16.7 | 40.0 | -28.6 | 20.0 | -16.7 | 200.0 | +650.0% |
| 2015 | -33.3 | 300.0 | -37.5 | -20.0 | -17.5 | -9.1 | 0.0 | 0.0 | 0.0 | -16.7 | 20.0 | -33.3 | −33.3% |
| 2014 | 100.0 | -20.0 | 0.0 | 0.0 | 25.0 | -40.0 | 0.0 | -33.3 | 0.0 | 0.0 | 0.0 | -25.0 | −40.0% |
| 2013 | 66.7 | 10.0 | -9.1 | 150.0 | -32.0 | 11.8 | -52.6 | 177.8 | 16.0 | -31.0 | -25.0 | -66.7 | −16.7% |
| 2012 | 5.6 | 110.5 | 0.0 | -25.0 | -26.7 | -22.7 | 64.7 | -10.7 | -8.0 | -8.7 | -66.7 | -14.3 | −66.7% |
| 2011 | 0.0 | 10.0 | 0.0 | 18.2 | -3.8 | 20.0 | -30.0 | -52.4 | 130.0 | -13.0 | 25.0 | -28.0 | −10.0% |
| 2010 | 10.0 | 47.7 | 23.1 | -18.8 | 18.5 | -46.8 | 46.3 | -31.7 | 34.1 | -45.5 | -16.7 | -20.0 | −50.0% |
| 2009 | -10.0 | -2.8 | 100.0 | 42.9 | 90.0 | -68.4 | 0.0 | 11.7 | -17.9 | -9.1 | -20.0 | 0.0 | −0.0% |
| 2008 | 14.3 | -18.8 | 7.7 | 0.0 | 35.7 | -21.1 | 6.7 | -12.5 | 14.3 | -37.5 | 60.0 | -50.0 | −42.9% |
| 2007 | 26.0 | 58.7 | -10.0 | -22.2 | 0.0 | 35.7 | -5.3 | -11.1 | 0.0 | 0.0 | -12.5 | 0.0 | +40.0% |
No analyst coverage for this instrument.
Mera Pharmaceuticals, Inc. focuses on the development and commercialization of natural products from microalgae using its proprietary and large-scale photobioreactor technology. The company is also involved in the development of sea salt; and operation of family entertainment center focused on promoting health and wellness through the Villari's system of martial arts. In addition, it provides food production and delivery services. Mera Pharmaceuticals, Inc. was founded in 1983 and is based in Las Vegas, Nevada.
No recent headlines.